bergapten

This page covers all bergapten drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Taste receptor type 2 member 10, Cytochrome P450 1A1, Amine oxidase [flavin-containing] A.

Targets

Taste receptor type 2 member 10, Cytochrome P450 1A1, Amine oxidase [flavin-containing] A

Phase 3 pipeline (1)

• Heraclin · Metabolic
  Heraclin works by inhibiting the enzyme Cytochrome P450 1A1, which plays a role in the metabolism of various substances in the body.

Patent intelligence

• bergapten patent landscape — aggregated cliff calendar, attackable patents, originator estates